Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

A novel thermally stable mRNA vaccine candidate protects mice against SARS-CoV-2 challenge

Aug. 24, 2020

Another obstacle to universal flu vaccine

Aug. 21, 2020

Phase I study results support further evaluation of yellow fever monoclonal antibody TY-014

Aug. 13, 2020

Recombinant SARS-CoV-2 S1-Fc fusion protein shows promise in animal species

Aug. 13, 2020

Positive interim data presented from EQUATE study of itolizumab in acute GvHD

Aug. 11, 2020

Sinovac's COVID-19 vaccine enters phase III testing in healthcare professionals

Aug. 10, 2020

FDA issues complete response letter for Viaskin Peanut

Aug. 4, 2020

Cynata reports 2-year data from phase I study of CYP-001 in acute GvHD

July 31, 2020

First phase II study of Lyme disease vaccine candidate VLA-15 meets endpoints

July 23, 2020

Dana-Farber Cancer Institute describes CDK7 inhibitors

July 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...